Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity

A functional polymorphism (−1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer

(2011) Li Liu et al.   CANCER

Hydrogen sulfide gas has cell growth regulatory role

(2011) Rajamanickam Baskar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

(2010) Jiahuai Tan et al.   Journal of Hematology & Oncology

Hydrogen Sulfide Regulates Cardiac Function and Structure in Adriamycin-Induced Cardiomyopathy

(2009) Yu-Wen Su et al.   CIRCULATION JOURNAL

Histone Deacetylase Inhibitors

(2009) Xujun Ma et al.   DRUGS

Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells

(2009) Terry W. Moody et al.   LUNG CANCER

Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway

(2008) Hyun-Min Park et al.   BIOCHEMICAL PHARMACOLOGY

New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity

(2008) Elena Perrino et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model

(2008) S. M. Eck et al.   BREAST CANCER RESEARCH AND TREATMENT

Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes

(2008) A M Calcagno et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer

(2008) W. Sauter et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HDAC family: What are the cancer relevant targets?

(2008) Olaf Witt et al.   CANCER LETTERS

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma

(2008) S. A. Wedel et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE